Search Results

Press Releases

Copan Diagnostics Announces FDA Clearance for Innovative Urine Collection Device

December 9, 2024

·

2 min read

Biotech Beach

Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities

Copan Diagnostics, a leader in Clinical Microbiology automation solutions, has announced the third FDA clearance for its innovative pre-analytical processor, Colibrí™.

January 29, 2024

·

4 min read

Business

Copan Diagnostics Announces Leadership Change - February 02, 2023

COPAN Group announces the departure of Norman Sharples, Chief Executive Officer of Copan Diagnostics, from the Company he co-founded with Daniele Triva in 1994 and the appointment of Fabrizio Mazzocchi as new CEO and member of Copan Diagnostics’ board of directors effective from January 9th, 2023.

February 2, 2023

·

2 min read

Biotech Beach

Colibrí™, COPAN’s Automated Specimen Workup Instrument, Receives FDA 510(k) Clearance for use with bioMérieux VITEK® 2 Antimicrobial Susceptibility Testing (AST) System

COPAN Diagnostics Inc. is proud to announce the second FDA clearance of Colibrí™, a semi-automated pre-analytical processor that is a complementary part of WASPLab®, COPAN’s full laboratory automation system.

October 10, 2022

·

4 min read

Biotech Beach

COPAN Diagnostics Unveils New Image in North America

For over 40 years, COPAN, a global leader in pre-analytics has helped to shape the standard for excellence in Clinical Microbiology with innovative sample collection and transport systems and cutting-edge solutions for laboratory automation and artificial intelligence.

June 10, 2022

·

2 min read

Policy

LUCIRA™ HEALTH Provides Statement on Copan’s Recall of its FLOQSwabs

Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, commented on the recent recall of the FLOQSwabs by supply partner Copan Italia SPA, or Copan.

October 8, 2021

·

4 min read

Policy

Colibri™ Automated Specimen Workup Instrument by COPAN Receives FDA 510(k) Clearance for Use with MALDI-TOF Mass Spectrometry Analyzers

COPAN Diagnostics is proud to announce the FDA clearance of Colibri™, an automated processor that is a complementary part of WASPLab®, COPAN’s full laboratory automation system.

January 5, 2022

·

4 min read

Biotech Beach

COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology

On the heels of recent news of FDA clearance for Colibri™, automated colony picking instrument for identification and antimicrobial susceptibility testing in clinical Microbiology, today COPAN announced the North American launch of PhenoMATRIX® TAG.

January 19, 2022

·

5 min read

Microbix & Copan Italia Execute Strategic AgreementFor FLOQ devices & QAPs Co-branding, IP licensing, Co-marketing, Purchase and Supply

Microbix Biosystems Inc., a life sciences innovator and exporter, and Copan Italia S.p.A., the global leader in specimen collection technologies, announce their execution of a strategic agreement in relation to Microbix’s quality assessment products and Copan’s flocked devices.

December 21, 2020

·

6 min read

Press Releases

Microbix Assisting EMQN with Novel Genetic-Test EQA Program

December 10, 2024

·

5 min read